Evidence map›Paper›PMID 32562209›Full record

ArticleJournal of clinical immunology2020

Everolimus-Induced Remission of Classic Kaposi's Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency.

Jin Yan Yap, Brian Gloss, Marcel Batten, Peter Hsu, Lucinda Berglund, Fenfen Cai, Pei Dai, Andrew Parker, Min Qiu, Wendell Miley and 13 more

Open access · greenAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Human inborn errors of immunity to oncogenic viruses.Current opinion in immunology · 2021
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Jin Yan YapImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
Brian GlossThe Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, Australia.
Marcel BattenImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
Peter HsuThe Children's Hospital at Westmead, Sydney, Australia.
Lucinda BerglundWestmead Hospital, Sydney, Australia.
Fenfen CaiWestmead Hospital, Sydney, Australia.
Pei DaiImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
Andrew ParkerDepartment of Anatomical Pathology, St Vincent's Hospital, Sydney, Australia.
Min QiuDepartment of Anatomical Pathology, St Vincent's Hospital, Sydney, Australia.
Wendell MileyViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Romin RoshanViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Vickie MarshallViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Denise WhitbyViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Eric WegmanSydney Clinic for Gastrointestinal Diseases, Sydney, Australia.
Roger GarsiaRoyal Prince Alfred Hospital, Sydney, Australia.
Kathy H C WuSt Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia.
Edwin KirkNSW Health Pathology, Sydney, Australia.
Mark PolizzottoSt Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia.
Elissa K DeenickImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
Stuart G TangyeImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
Cindy S MaImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia.
CircaClinical Immunogenomics Research Consortium Australia, Sydney, Australia.
Tri Giang PhanImmunology Division, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, Sydney, NSW, 2010, Australia. t.phan@garvan.org.au.ORCID 0000-0002-4909-2984
Garvan Institute of Medical Research · AULeidos (United States) · USSt Vincent's Hospital Sydney · AUWestmead Hospital · AUChildren's Hospital at Westmead · AUNew South Wales Department of Health · AURoyal Prince Alfred Hospital · AUThe University of Sydney · AUUNSW Sydney · AU

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
CCR NIH HHS HHSN261200800001CNCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alternative SplicingAntineoplastic AgentsCellular ReprogrammingCTLA-4 AntigenEverolimusHaploinsufficiencyHumansMaleMiddle AgedRemission InductionSarcoma, KaposiT-LymphocytesAntineoplastic AgentsCTLA-4 AntigenCTLA4 protein, humanEverolimus

Identifiers

PMID32562209
PMCPMC8996434
OpenAlexW3036830195

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.